Review article: the evolution of endpoint assessments for chemotherapy‐induced nausea and vomiting and post‐operative nausea and vomiting—a perspective from the US Food and Drug Administration-Reference-Cited by-同舟云学术

Review article: the evolution of endpoint assessments for chemotherapy‐induced nausea and vomiting and post‐operative nausea and vomiting—a perspective from the US Food and Drug Administration

Published:2021-05-12 Issue:1 Volume:54 Page:7-13
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Gabby Maegan E.¹,Bugin Kevin¹,Lyons Erica¹^ORCID

Affiliation:

1. Division of Gastroenterology Center for Drug Evaluation and Research Office of New Drugs The U.S. Food and Drug Administration Silver Spring MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16386

Reference10 articles.

1. Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment

2. Postoperative Nausea and Vomiting

3. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines

4. Defining the Emetogenicity of Cancer Chemotherapy Regimens: Relevance to Clinical Practice

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial;Journal of Clinical Oncology;2024-09-06

2. Antiemetic prophylaxis in hematologic malignancies patients receiving conditioning protocols for hematopoietic stem cell transplantation: A study protocol for a systematic review;Farmacia Hospitalaria;2023-11

3. [Artículo traducido] Profilaxis antiemética en pacientes con neoplasias hematológicas que reciben protocolos de acondicionamiento para el trasplante de células madre hematopoyéticas: protocolo de estudio para una revisión sistemática;Farmacia Hospitalaria;2023-11

4. An assessment of the effects of neurokinin₁ receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development;British Journal of Clinical Pharmacology;2023-08-17

5. Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin;Cancer Communications;2022-12-22